Stock·NYSE·Technology
Zeta Global Holdings Corp. (ZETA)
- Market cap
- $8.74B
- P/E
- n/m
- Dividend yield
- No dividend
- Street target
- $38.00median of 15 analysts
- 52-week range
- $14.37 $35.75
ZETA stock forecast today
Where ZETA stands today, and what CleaRank Financial AI makes of it.
ZETA at a glance
Zeta Global Holdings Corp. (ZETA): Buy, 73/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($31.80 and $22.87).
- Insiders Insiders sold $400K and made no open-market purchases over the last 18 months.
Figures as of November 10, 2026.
CleaRank Financial AI
ZETA receives a CleaRank rating of Buy with a model score of 73/100.
Trend adds the most to that score: the price is 53.34% above its 200-day average and 10.28% above its 50-day average, while the 50-day average is 39.05% above the 200-day. Valuation takes the most away, since the company has no meaningful P/E because it lost money. The 50-day average is $31.80 and the 200-day is $22.87. The price rose 76.32% over the past year.
Only on CleaRank
Figures we compute ourselves from ZETA's own price, earnings and insider-filing history. Tap one to see it in context.
ZETA stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $35.07 is 10.3% above the 50-day simple moving average of $31.80.Price above its 200-day average ›
The price is 53.3% above the 200-day simple moving average of $22.87.50-day average above the 200-day ›
The 50-day average ($31.80) is 39.0% above the 200-day average ($22.87), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 97% of its 52-week range, between $14.37 and $35.75.
ZETA share price
Pick a period: each tab shows how far ZETA has moved over it, to the last close.
Today's trading
Where ZETA sits inside today's range and its 52-week range.
ZETA fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 5.56 is 26.8% below the sector median of 7.6.Not profitable over the last 12 months ›
Net income over the last 12 months was -$2.2M on revenue of $1.6B, a net margin of -0.1%.
Key statistics
The headline figures for ZETA.
As of November 10, 2026, ZETA trades at $35.07, with a market value of $8.74B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of ZETA's valuation, growth and risks.
ZETA cannot be judged on a P/E, which is not meaningful because its earnings per share over the last 12 months are negative. To put the size in context, ZETA has a market capitalisation of $8.7B and trailing earnings of -$0.01 a share.
ZETA is still losing money. Its net margin stands at -0.14% and its operating margin at 3.82%, and return on equity of -0.27% is below the sector median of 13.4%. Revenue growth of 43.50% puts it 19.3 percentage points faster than the sector median of 24.2%. Debt-to-equity of 0.24 describes the balance sheet.
For this fiscal year, analysts expect earnings per share of $0.95, which would be growth of 6.6%. For next year their average estimate is $1.20, growth of 26.9%.
Expect day-to-day swings. A typical session moves ZETA by 3.28%, and its beta against the S&P 500 is 1.25. Over the last 18 months insiders sold $400K of stock and bought none on the open market. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market purchases would.
ZETA against the Technology sector
How ZETA compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, ZETA trades at 5.56x, -27% versus the sector median of 7.60x.
Return vs XLK: Since May 30, 2025, ZETA has gained 166.9% against a gain of 46.3% for XLK.
Performance against XLK
ZETA and the Technology sector fund over the same days.
Revenue and earnings
How much ZETA sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); ZETA reported again on November 9, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 29.7% in FY2025 to $1.3B, from $1.0B a year earlier.
Profit margin: The net margin was -2.4% in FY2025, up from -6.9% the year before.
Loss-making: ZETA lost $31.5M in FY2025.
ZETA AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 61.1, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 61.1 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of ZETA
The score, the reasoning behind it, and what could move the price next.
Zeta Global Holdings Corp. (ZETA) has an upward trend. The price of $35.07 sits 53.34% above its 200-day average of $22.87 and 10.28% above its 50-day average of $31.80. Near the top of its 52-week range, the price is 1.90% below the high of $35.75 and 144.14% above the low of $14.37. The 50-day average is 39.05% above the 200-day average, a sign that the rise is backed by the averages rather than working against them.
The 14-day RSI of 61.1 is in the bullish zone, below the overbought line, and the MACD line is positive. The recent returns are all positive: the price rose 20.31% over the past three months, rose 115.82% over the past six months and rose 76.32% over the past year. Volume in the last session ran 104.1% above its average, on a day the price rose 8.17%.
Analyst upgrade ›
Goldman Sachs upgraded it to Buy from Neutral on October 16, 2026.
Source: Analyst action, Goldman Sachs, October 16, 2026
- Keep an eye on the two nearest levels: the 52-week high at $35.75 sits above the price, while the 20-day EMA at $32.27 sits below it.
- A 14-day RSI of 61.1 sits in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
The uptrend rests on ZETA staying above its 50-day average at $31.80 and its 200-day average at $22.87; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $32.27.
Overhead, the next level for ZETA is the 52-week high at $35.75. The RSI in the bullish zone suggests momentum still supports a move higher.
Technical indicators
Momentum and trend for ZETA, from its daily closes.
As of November 10, 2026, with ZETA at $35.07, its 14-day RSI is 61.1 (showing bullish momentum without being overbought), its 50-day simple moving average is $31.80 and its 200-day is $22.87.
Calculated by CleaRank on daily closes as of November 10, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What ZETA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 10, 2026, ZETA's 1-year correlation of daily returns is +0.42 with S&P 500 (SPY), +0.40 with Nasdaq 100 (QQQ), +0.32 with Bitcoin (BTC) and +0.07 with gold (XAU).
ZETA price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
13 of 15 analysts rate it a buy or strong buy, 2 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $38.00 is 8.4% above the price.Buy share not up from three months ago ›
13 of 15 rate it a buy now, against 13 of 15 three months ago.
ZETA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 16, 2026 | Goldman Sachs | Upgrade | Buy |
| Oct 12, 2026 | Roth Capital | Reiterates | Buy |
| Oct 9, 2026 | Truist Securities | Maintains | Buy |
| Oct 9, 2026 | RBC Capital | Reiterates | Outperform |
| Oct 9, 2026 | Keybanc | Maintains | Overweight |
| Oct 9, 2026 | Canaccord Genuity | Maintains | Buy |
As of November 10, 2026, 15 Wall Street analysts cover ZETA: 13 rate it a buy or strong buy, 2 a hold and 0 a sell or strong sell. Their 12-month price targets range from $25.00 to $55.00. The median ZETA price target is $38.00, 8.4% above the price of $35.07.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
ZETA risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much ZETA tends to move, against the market and on its own.
ZETA price history and drawdowns
ZETA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Typical daily move of 2% or more ›
A typical daily move is 3.28% (the standard deviation of the last 30 daily returns).Not yet recovered from its worst fall ›
The worst fall was 70.0%, from November 2024 to April 2025; the price is still 4.5% below that peak.Most 1-year holds ended higher ›
67% of 1-year holding periods in the last 5 years ended with a gain.Beat the S&P 500 since July 2021 ›
$10,000 invested in July 2021 is now worth $43,892, against $18,683 in the S&P 500 (SPY).
ZETA Drawdowns & Recovery
As of November 10, 2026, ZETA's worst peak-to-trough fall over the period since July 2021 was -70.0% (November 2024 to April 2025); it is still 4.5% below that peak, and 67% of 1-year holding periods ended with a gain.
From weekly closing values. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ZETA in July 2021 is worth now, against the same amount in the S&P 500.
Against the market: ZETA beat the S&P 500 over this period: $43,892 against $18,683.
A $10,000 investment in ZETA in July 2021 would be worth about $43,892 today, compared with about $18,683 for the same investment in the S&P 500 benchmark with its dividends reinvested.
Seasonal patterns
Which calendar months have been kind to ZETA, and which have not.
Strongest month, August: an average of +22.28%, up in 5 of 6 years.
Weakest month, June: an average of -8.94%, up in 1 of 5 years.
This month, November: has averaged -2.88%, up in 2 of 5 years. Past seasonality does not repeat on schedule.
Across 6 calendar years of history, ZETA's strongest calendar month has been August (average +22.28%, up in 5 of 6 years) and its weakest June (average -8.94%, up in 1 of 5 years).
Average return for each calendar month across 6 calendar years of history, from weekly closing prices.
ZETA stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ZETA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 5 years of price history, projects that a $10,000 investment in ZETA today could grow to about $15,314 by 2030 in the base case, with a 90th-percentile outcome near $55,167 and a 10th-percentile outcome around $4,251. Projections are statistical simulations, not guarantees.
ZETA Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $53.71 for ZETA by 2030 in the base case, from $35.07 today (1.5x over 4 years). The 10th-percentile path ends near $14.91. These are outcomes of a Monte Carlo simulation run on ZETA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $20.55 | $39.01 | $74.05 | |
| 2028 | $17.54 | $43.40 | $107 | |
| 2029 | $15.91 | $48.28 | $146 | |
| 2030 | $14.91 | $53.71 | $193 |
Method: a lognormal simulation of ZETA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ZETA is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
ZETA insider trading
What the people running the company have bought and sold.
ZETA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought ZETA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 10, 2026, ZETA insiders reported 2 open-market sales worth $400K and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | William A Landman
Director
|
Grant | 791 | $25.0K |
| Aug 14, 2026 | Satish Ravella
Officer
|
Grant | 25.8K | - |
| Aug 12, 2026 | Satish Ravella
Officer
|
Option | 6.3K | $78.5K |
| Jul 1, 2026 | Jene Elzie
Director
|
Grant | 7.2K | - |
| Jul 1, 2026 | William A Landman
Director
|
Grant | 8.5K | $25.0K |
| Jul 1, 2026 | Robert H Niehaus
Director
|
Grant | 7.2K | - |
| Jul 1, 2026 | William T. Royan
Director
|
Grant | 7.2K | - |
| Jul 1, 2026 | Jeanine Silberblatt
Director
|
Grant | 7.2K | - |
| Jun 12, 2026 | Jeanine Silberblatt
Director
|
Sell | 7.5K | $149.2K |
| Jun 4, 2026 | Satish Ravella
Officer
|
Grant | 8.0K | - |
| Jun 2, 2026 | Satish Ravella
Officer
|
Option | 25.0K | $314.0K |
| May 20, 2026 | Steven H Gerber
President
|
Grant | 724.0K | - |
| May 20, 2026 | Christopher E Greiner
Chief Financial Officer
|
Grant | 633.1K | - |
| May 7, 2026 | Robert H Niehaus
Director
|
Grant | 60.0K | - |
| May 6, 2026 | David A. Steinberg
Chief Executive Officer
|
Grant | 1.3M | - |
| Apr 1, 2026 | William A Landman
Director
|
Grant | 1.6K | $25.0K |
| Dec 31, 2025 | William A Landman
Director
|
Grant | 1.2K | $25.0K |
| Dec 31, 2025 | Satish Ravella
Officer
|
Grant | 100.0K | - |
| Dec 12, 2025 | Jeanine Silberblatt
Director
|
Sell | 13.0K | $251.2K |
| Dec 12, 2025 | David A. Steinberg
Chief Executive Officer
|
Grant | 698.9K | - |
| Dec 5, 2025 | Christopher E Greiner
Chief Financial Officer
|
Grant | 515.6K | - |
| Dec 5, 2025 | Satish Ravella
Officer
|
Grant | 74.3K | - |
| Nov 19, 2025 | William A Landman
Director
|
Grant | 12.0K | - |
| Nov 14, 2025 | Steven H Gerber
President
|
Grant | 684.8K | - |
| Oct 1, 2025 | William A Landman
Director
|
Grant | 1.3K | $25.0K |
| Aug 22, 2025 | David A. Steinberg
Chief Executive Officer
|
Grant | 840.6K | - |
| Jul 1, 2025 | Jene Elzie
Director
|
Grant | 9.9K | - |
| Jul 1, 2025 | Imran Khan
Director
|
Grant | 9.9K | - |
| Jul 1, 2025 | William A Landman
Director
|
Grant | 11.5K | $25.0K |
| Jul 1, 2025 | Robert H Niehaus
Director
|
Grant | 9.9K | - |
| Jul 1, 2025 | William T. Royan
Director
|
Grant | 9.9K | - |
| Jul 1, 2025 | Jeanine Silberblatt
Director
|
Grant | 9.9K | - |
Source: TwelveData, from SEC Form 4 filings
ZETA stock forecast: questions people ask
Answered from the figures on this page, as of November 10, 2026.